Christopher Zosh

Christopher Zosh is the current VP of finance at Cleveland BioLabs. Prior to their current position, they were with Panacela Labs, Inc. as their Executive Vice President of Finance. Christopher has been in this role since April 2014 and is responsible for the administrative, financial, and risk management operations of the organization. This includes SEC Reporting, compilation and production of financial reports, financial audits, tax audits and filings, investor communications, and corporate contracts. Christopher has also been responsible for development and management of the annual budget as well as spearheading due diligence for potential M&A transactions. Under their leadership, the company has successfully raised over eighteen million dollars from the private investment community.

Christopher Zosh earned a Bachelor of Science in Business Administration from the University at Buffalo.

Some of their coworkers include Andrei Gudkov - Chief Scientific Officer, Andrei Purmal - Vice President, Chemistry, and Ann Hards - Executive Vice President Regulatory Affairs. Their manager is Langdon Miller, President, Chief Medical Officer.